Related Experiment Video
Updated: Jul 17, 2025

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
8.7K
Use of Circulating Tumor DNA to Monitor Minimal Residual Disease Among Patients With Colorectal Cancer
1University of Kentucky.
Clinical Journal of Oncology Nursing
|September 7, 2023
Abstract:
The emergence of molecular analysis approaches that use circulating tumor DNA (ctDNA) to measure minimal residual disease is shifting the management of colorectal cancer and many solid tumor cancers. Analysis of ctDNA has sev.

